Alnylam Pharmaceuticals
ALNY
#547
Rank
โ‚ฌ37.95 B
Marketcap
287,26ย โ‚ฌ
Share price
0.31%
Change (1 day)
7.22%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company